These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prostaglandins in peptic ulcer disease. An overview of current status and future directions. Sontag SJ Drugs; 1986 Nov; 32(5):445-57. PubMed ID: 3792228 [TBL] [Abstract][Full Text] [Related]
4. Importance of gastric acid in gastric ulcer formation in rabbits with antibody-induced prostaglandin deficiency. Lee M; Aldred K; Lee E; Prince MD; Feldman M Gastroenterology; 1992 Nov; 103(5):1467-74. PubMed ID: 1426865 [TBL] [Abstract][Full Text] [Related]
5. Generation of prostaglandins in gastric mucosa of patients with peptic ulcer disease: effect of nonsteroidal antiinflammatory compounds. Konturek SJ; Obtulowicz W; Kwiecien N; Oleksy J Scand J Gastroenterol Suppl; 1984; 101():75-7. PubMed ID: 6599541 [TBL] [Abstract][Full Text] [Related]
6. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer]. Fich A; Stalnikowicz R; Goldin E; Eliakim R; Wengrower D; Ligumsky M; Karmeli F; Rachmilewitz D Harefuah; 1986 Nov; 111(10):292-5. PubMed ID: 3817615 [No Abstract] [Full Text] [Related]
7. Role of endogenous prostaglandins in gastric secretion and mucosal defense. Cohen MM Clin Invest Med; 1987 May; 10(3):226-31. PubMed ID: 3040310 [TBL] [Abstract][Full Text] [Related]
8. [Prostaglandin and cyclic nucleotide levels in patients with peptic ulcer and chronic gastritis with secretory insufficiency]. Valenkevich LN; Zaĭchuk ASh Ter Arkh; 1987; 59(2):29-31. PubMed ID: 3472366 [TBL] [Abstract][Full Text] [Related]
9. Defects in prostaglandin synthesis and metabolism in ulcer disease. Malagelada JR; Ahlquist DA; Moore SC Dig Dis Sci; 1986 Feb; 31(2 Suppl):20S-27S. PubMed ID: 3510842 [TBL] [Abstract][Full Text] [Related]
10. [Aggression or protection of the gastric mucosa in the pathogenesis of peptic ulcer and prostaglandins and the problem of treatment]. Rybicka J Pol Arch Med Wewn; 1983 Oct; 70(4):189-96. PubMed ID: 6364053 [No Abstract] [Full Text] [Related]
12. Ulcer-healing drugs and endogenous prostaglandins. Guslandi M Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):398-402. PubMed ID: 2864318 [TBL] [Abstract][Full Text] [Related]
13. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease. Wilson DE Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241 [TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of peptic ulcer. Ivey KJ Aust N Z J Med; 1974 Feb; 4(1):71-4. PubMed ID: 4367503 [No Abstract] [Full Text] [Related]
16. Effects of carbenoxolone on gastric release of prostaglandin (PG)E2 in patients with peptic ulcer disease. Rask-Madsen J; Bukhave K; Madsen PE; Bekker C Acta Gastroenterol Belg; 1983; 46(9-10):419-28. PubMed ID: 6585111 [No Abstract] [Full Text] [Related]
17. [The place and role of prostaglandins in the physiopathology of the stomach]. Andreica V Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(5):411-20. PubMed ID: 6143359 [No Abstract] [Full Text] [Related]